menu
    • menu

    Company profile for Casma Therapeutics

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    New discoveries are revealing the fundamental role of autophagy and lysosomal flux in maintaining cellular health. Furthermore, it is now appreciated that inadequate or aberrant autophagy contributes to a wide range of diseases. We are focused on boosting autophagy – pioneering novel therapeutic strategies to address unmet medical needs. We are creating a new target set for drug discovery and development, and advancing innov...
    New discoveries are revealing the fundamental role of autophagy and lysosomal flux in maintaining cellular health. Furthermore, it is now appreciated that inadequate or aberrant autophagy contributes to a wide range of diseases. We are focused on boosting autophagy – pioneering novel therapeutic strategies to address unmet medical needs. We are creating a new target set for drug discovery and development, and advancing innovative paradigms to treat a broad set of illnesses that are either neglected or inadequately addressed today.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Casma TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    400 Technology Square, Suite 201 Cambridge, MA 02139
    Telephone
    Telephone
    (857) 777-4990
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.casmatx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/casma-tx/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/casmatx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Casma Therapeutics Nominates CSM-101 for Parkinson's Treatment
    Casma Therapeutics Nominates CSM-101 for Parkinson's Treatment

    05 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250605004274/en/Casma-Therapeutics-Nominates-CSM-101-as-a-Development-Candidate-for-the-Treatment-of-Rare-and-Common-Forms-of-Parkinsons-Disease

    BUSINESSWIRE
    05 Jun 2025
    Share Share
    Casma Therapeutics Announces CEO Transition
    Casma Therapeutics Announces CEO Transition

    31 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230131005087/en

    BUSINESSWIRE
    31 Jan 2023
    Share Share
    Casma Therapeutics Raises $46.0 M in Series C Funding
    Casma Therapeutics Raises $46.0 M in Series C Funding

    15 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221115005125/en

    BUSINESSWIRE
    15 Nov 2022
    Share Share
    Casma Therapeutics to Present at UBS 2022 Global Healthcare Conference
    Casma Therapeutics to Present at UBS 2022 Global Healthcare Conference

    17 May 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/05/17/2445420/0/en/Casma-Therapeutics-to-Present-at-UBS-2022-Global-Healthcare-Conference.html

    GLOBENEWSWIRE
    17 May 2022
    Share Share
    Casma Tx to Participate at 21st Annual Needham Virtual Healthcare Conference
    Casma Tx to Participate at 21st Annual Needham Virtual Healthcare Conference

    07 Apr 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/04/07/2418914/0/en/Casma-Therapeutics-to-Participate-at-21st-Annual-Needham-Virtual-Healthcare-Conference.html

    GLOBENEWSWIRE
    07 Apr 2022
    Share Share
    Casma Therapeutics to Present at the UBS Virtual Biotechnology Symposium
    Casma Therapeutics to Present at the UBS Virtual Biotechnology Symposium

    16 Sep 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/09/15/2297964/0/en/Casma-Therapeutics-to-Present-at-the-UBS-Virtual-Biotechnology-Private-Company-Symposium.html

    GLOBENEWSWIRE
    16 Sep 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search